EN
抗体药类似物
Research Grade Belimumab
All
  • CatalogTD-HV212016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsLymphoStat-B,hBlySmAb-1.1,CAS:356547-88-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Belimumab


Catalog No. TD-HV212016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-lambda
Expression system Mammalian Cells
Clonality Monoclonal
Target BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9Y275
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names LymphoStat-B,hBlySmAb-1.1,CAS:356547-88-1
Background Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV212016_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Belimumab.